期刊文献+

炎性因子在慢性阻塞性肺疾病急性加重期的作用研究 被引量:3

The Role of Inflammatory Factor in the Exacerbation of Chronic Obstructive Pulmonary Diseases
在线阅读 下载PDF
导出
摘要 目的:探讨慢性阻塞性肺疾病急性加重(AECOPD)患者治疗前后血IL-10、IL-23、CRP等炎症因子的浓度变化及其与肺功能损害的相关性。方法:采用ELISA分析30例AECOPD患者治疗前后血清IL-10、IL-23、C-反应蛋白,测PaO2、FEV1(、FEV1/FVC%、外周血白细胞计数和中性粒细胞百分比,分析IL-10、IL-23、CRP与FEV1(和FEV1/FVC%的相关性。结果:在AECOPD患者中,治疗前后IL-10浓度分别为(179.9±73.8 pg/L)和(223.5±107.8 pg/L),比对照组(364.3±160.2pg/L)低;治疗前后IL-23浓度分别为(189.4±103.7 pg/L)和(177.2±103.2 pg/L),均比对照组(89.7±64.4pg/L)高;治疗前后CRP浓度分别为(24.1±18.2mg/L)和(10.2±4.6 mg/L),均比对照组(5.6±1.9 mg/L)高;差异均有统计学意义。IL-10浓度与FEV1、FEV1/FVC变化呈正相关(r=0.782,r=0.575,P<0.05);IL-23浓度与FEV1、FEV1/FVC呈负相关(r=-0.586,r=-0.453,P<0.05);CRP浓度与FEV1、FEV1/FVC呈负相关(r=-0.725,r=-0.643,P<0.05)。结论:AECOPD患者血IL-10浓度较对照组低,而IL-23和CRP浓度较对照组高;血IL-10、IL-23和CRP的浓度与肺功能损害程度相关。 Objective:To investigate the changes of Interleukin-10(IL-10),Interleukin-23(IL-23) and C-reactive protein(CRP) levels in patients with acute exacerbation of chronic obstructive pulmonary diseases (AECOPD) and to analyze the correlation between the inflammatory factor and COPD.Methods:The levels of IL-10,IL-23 and CRP in thirty cases of patients with AECOPD were measured by enzyme-linked immunosorbent assay.The amounts of neutrophils,PaO2 and lung function indexes such as the forced expiratory volume in one...
出处 《华西医学》 CAS 2008年第5期1049-1051,共3页 West China Medical Journal
关键词 慢性阻塞性肺疾病 白细胞介素-10 白细胞介素-23 C-反应蛋白 chronic obstructive pulmonary disease interleukin-10 interleukin-23 C-reactive protein
  • 相关文献

参考文献18

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8245
  • 2[2]Lopez AD,Shibuya K,Rao C,et al.Chronic obstructive pulmonary disease:current burden and future projections[J].Eur Respir J,2006,27(2):397-412.
  • 3[3]Moore KW,de Waal Malefyt R,Coffman RL,et al.Interleukin-10 and IL-10 receptor[J].Annu Rov Immunol,2001,19:683-765.
  • 4[4]Hubbard,R and A.Tattersfield.Inhaled corticosteroids,bone mineral density and fracture in older people[J].Drugs Aging,2004,21:631-8.
  • 5[5]Allegra L,Blasi F,de Bernardi B,et al.Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis:a re-evaluation of previously published data of a placebo-controlled randomized study[J].Pulmpharmacol Ther,2001,14(2):149-55.
  • 6[6]Sethi S,Breton J,Wynne B,et al.Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis[J].Antimicrob Agents Chemother,2005,49(1):153-60.
  • 7[7]Romani,L.and P.Puccetti.Protective tolerance to fungi:the role of IL-10 and tryptophan catabolism[J].Trends Microbiol,2006,14(4):183-9.
  • 8[8]Takanashi S,Hasegawa Y,Kanehira Y,et al.Interleukin-10 level in sputum is reduced in bronchial asthmas,COPD and in smokes[J].Eur Respir J,1999,14(2):309-14.
  • 9[9]Peter J Barnes.Mediators of Chronic Obstructive Pulmonary Disease[J].Pharmacol Rev,2004,56:515-48.
  • 10[10]BreenD,Wilson S,Djukanovic R,et al.Inflammatory cells in the airways in COPD[J].Thorax,2006,61:448-54.

二级参考文献7

共引文献8244

同被引文献24

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部